Schroeder Martin, Donas Konstantinos P, Stavroulakis Konstantinos, Stachmann Arne, Torsello Giovanni, Bisdas Theodosios
1 Department of Vascular Surgery, University of Münster, Germany.
2 St. Franziskus Hospital Münster, Germany.
J Endovasc Ther. 2017 Apr;24(2):223-229. doi: 10.1177/1526602816684628. Epub 2017 Jan 1.
To examine the suitability of the Zenith off-the-shelf (p-branch) endograft in patients with juxta- or pararenal abdominal aortic aneurysms (J/PRAA) previously treated with endovascular aneurysm repair incorporating the chimney technique (chEVAR).
Between January 2012 and December 2014, high-resolution computed tomography angiograms and clinical data from 50 patients (mean age 79 years; 45 men) with J/PRAAs treated with chEVAR were retrospectively reviewed. Primary anatomical suitability was evaluated according to the Investigational Device Exemption protocol for the Zenith p-branch endograft in a dedicated 3-dimensional vascular workstation. Secondary suitability was defined as any additional intervention needed to overcome adverse anatomical conditions at the access vessels. The Zenith p-branch endograft is available in 2 configurations (A and B), with the main difference being the distance between the superior mesenteric artery (SMA) and the renal fenestrations.
The p-branch endograft showed a primary suitability of 54% (n=27). Each configuration was suitable in 18 (36%) patients. Main anatomical limitations were the clock position of the left renal artery (LRA; n=7, 14%), the distance between the SMA and LRA (A: n=16, 32%; B: n=16, 32%), and significantly narrowed or calcified iliac arteries. If additional interventions at the access vessels were employed, a secondary suitability of 64% (n=32) could be achieved.
In this specific group of patients treated with chEVAR, the Zenith p-branch system would be suitable in about half of the patients, which could be raised to two-thirds with ancillary access vessel procedures. A prospective clinical study is warranted to evaluate these results.
探讨Zenith现成(p型分支)腔内移植物在先前采用烟囱技术(chEVAR)进行血管腔内动脉瘤修复术治疗的近肾或肾旁腹主动脉瘤(J/PRAA)患者中的适用性。
回顾性分析2012年1月至2014年12月期间50例(平均年龄79岁;45例男性)接受chEVAR治疗的J/PRAA患者的高分辨率计算机断层扫描血管造影和临床资料。在专用的三维血管工作站中,根据Zenith p型分支腔内移植物的研究器械豁免方案评估主要解剖学适用性。次要适用性定义为克服入路血管不利解剖条件所需的任何额外干预措施。Zenith p型分支腔内移植物有两种配置(A和B),主要区别在于肠系膜上动脉(SMA)与肾开窗之间的距离。
p型分支腔内移植物的主要适用性为54%(n = 27)。每种配置在18例(36%)患者中适用。主要解剖学限制因素为左肾动脉(LRA)的时钟位置(n = 7,14%)、SMA与LRA之间的距离(A:n = 16,32%;B:n = 16,32%)以及显著狭窄或钙化的髂动脉。如果对入路血管采用额外干预措施,则次要适用性可达64%(n = 32)。
在这组接受chEVAR治疗的特定患者中,Zenith p型分支系统约适用于一半的患者,通过辅助入路血管手术可将适用性提高至三分之二。有必要进行一项前瞻性临床研究来评估这些结果。